Expression and Function of Ghrelin and Its Receptor, Growth Hormone Secretagogue Receptor TWEAK Protein and Its Receptor Fn14 in Human Endometrial Cancer
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Endometrial Cancer
Female
Endometrial Cancer
Trial Information
Expression and Function of Ghrelin and Its Receptor, Growth Hormone Secretagogue Receptor TWEAK Protein and Its Receptor Fn14 in Human Endometrial Cancer
Inclusion Criteria:
- women aged 18 years or older
- having a hysterectomy for the treatment of endometrial cancer, fibroids, chronic
pelvic pain or abnormal uterine bleeding
- have provided informed consent
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Principal Investigator
Chen Chen, MD PhD
Investigator Role:
Study Chair
Investigator Affiliation:
The University of Queensland
Authority:
Australia: National Health and Medical Research Council
Study ID:
Endo01
NCT ID:
NCT01075386
Start Date:
October 2009
Completion Date:
April 2013
Related Keywords:
- Endometrial Cancer
- Hysterectomy
- Endometrial cancer
- Benign
- Endocrine system
- Tissue collection
- Endometrial Neoplasms
- Sarcoma, Endometrial Stromal
- Adenoma
Name | Location |
|---|
